Protagonist Therapeutics, Inc. · NASDAQ:PTGX

Farallon Capital Management, L.L.C. reported a 9.99% stake in Protagonist Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 13, 2026

Farallon Capital Management, L.L.C. reported a 9.99% stake in Protagonist Therapeutics, Inc., 6,433,119 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
6,433,119
Intent
Passive
What changed
Stake changed
Filed together
29 holders

The filing in full

HolderStakeShares
Farallon Capital Management, L.L.C.9.99%6,433,119
Farallon Capital Partners, L.P.0%0
Farallon Capital Institutional Partners, L.P.0%0
Farallon Capital Institutional Partners II, L.P.0%0
Farallon Capital Institutional Partners III, L.P.0%0
Four Crossings Institutional Partners V, L.P.0%0
Farallon Capital Offshore Investors II, L.P.0%0
Farallon Capital (AM) Investors, L.P.0%0
Farallon Capital F5 Master I, L.P.0%0
Farallon Healthcare Partners Master, L.P.0%0
Farallon Partners, L.L.C.0%0
Farallon Institutional (GP) V, L.L.C.0%0
Farallon F5 (GP), L.L.C.0%0
Farallon Healthcare Partners (GP), L.L.C.0%0
Dapice Joshua J.9.99%6,433,119
Dreyfuss, Philip D.9.99%6,433,119
Dunn Hannah E.9.99%6,433,119
Gehani, Varun N.9.99%6,433,119
Giauque, Nicolas9.99%6,433,119
Husen, Avner A.9.99%6,433,119
Kim, David T.9.99%6,433,119
Linn, Michael G.9.99%6,433,119
Luo Patrick (Cheng)9.99%6,433,119
Roberts, Jr., Thomas G.9.99%6,433,119
Saito Edric C.9.99%6,433,119
Short Daniel S.9.99%6,433,119
Spokes, Andrew J. M.9.99%6,433,119
Warren, John R.9.99%6,433,119
Wehrly, Mark C.9.99%6,433,119

Source

View original at SEC

Related